Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) has shared an announcement.
MicroPort CardioFlow Medtech Corp. has announced an extraordinary general meeting to discuss a proposed merger with MicroPort Cardiac Rhythm Management Limited. The merger involves issuing new shares to the target company’s shareholders, which could significantly impact the company’s market position and shareholder value.
The most recent analyst rating on (HK:2160) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on MicroPort CardioFlow Medtech Corp. stock, see the HK:2160 Stock Forecast page.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corp. is a company incorporated in the Cayman Islands, focusing on the medical technology industry. It specializes in the development and manufacturing of cardiovascular devices, aiming to provide innovative solutions for cardiac rhythm management.
Average Trading Volume: 7,409,061
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.63B
See more data about 2160 stock on TipRanks’ Stock Analysis page.